Skip to Content
  • MyChart

    Log in to our secure, personalized website to manage your care (formerly myMDAnderson).

  • Request an Appointment

    If you are ready to make an appointment, select a button on the right. If you have questions about UT MD Anderson’s appointment process, our information page may be the best place to start.

    Appointment Information
    New Patients Current Patients Referring Physicians
  • Every Breakthrough
    Begins With You

    Gifts to UT MD Anderson’s historic philanthropic campaign help accelerate discovery, transform lives and bring hope to more patients than ever before.

    Learn more about Only Possible Here
    Donate Today only-possible-here-logo
The University of Texas MD Anderson Cancer Center
  • Clinical Trials
  • Locations
  • Careers
  • Contact Us
  • Our Doctors
    • Español
    • عربى
    • 中文
    • Türkçe
Clear
close
      MyChart
      Donate Today
      • Clinical Trials
      • Locations
      • Careers
      • Contact Us
        • Español
        • عربى
        • 中文
        • Türkçe
      • Request an Appointment
      • New Patients
      • Current Patients
      • Referring Physicians
      • Patients & Family
          • Becoming Our Patient Home
          • Why UT MD Anderson
          • Planning for Care
          • Getting to UT MD Anderson
          • While You're Here
          • International Center
          • Services and Amenities
          • Insurance & Billing
          • Second Opinion Appointments
          • Diagnosis & Treatment Home
          • Cancer Types
          • A New Diagnosis
          • Treatment Options
          • Care Centers & Clinics
          • Emotional & Physical Effects
          • Patient Support
          • Clinical Trials
          • Supporting a Loved One Home
          • Caregiver Roles & Challenges
          • Children and Teens
          • Taking Care of Yourself
          • Helping a UT MD Anderson Patient
          • Dealing with Loss
          • Life After Cancer Home
          • Follow-up Care After Cancer Treatment
          • Long-Term Effects of Cancer
          • Social & Emotional Impacts of Cancer
          • Legal & Financial Impacts of Cancer
          • Survivorship Week
        • Request an Appointment Current Patients

          Find information and resources for current and returning patients.

          Clinical Trials

          Learn about clinical trials at UT MD Anderson and search our database for open studies.

      • Prevention & Screening
          • Manage Your Risk Home
          • Tobacco Control
          • Diet
          • Body Weight
          • Physical Activity
          • Skin Safety
          • HPV
          • Hepatitis
          • Alcohol
          • Family History Home
          • Genetic Testing
          • Hereditary Cancer Syndromes
          • Genetic Counseling and Testing FAQs
          • Cancer Screenings Home
          • Mammograms & Breast Cancer Screening
          • Cervical Cancer Screening
          • Colorectal Cancer Screening
          • Endometrial Cancer Screening
          • Liver Cancer Screening
          • Lung Cancer Screening
          • Mobile Mammography
          • Ovarian Cancer Screening
          • Prostate Cancer Screening
          • Skin Cancer Screening
          • Women's Cancer Screening
          • Men's Cancer Screening
        • Cancer Prevention Center 

          The Lyda Hill Cancer Prevention Center provides cancer risk assessment, screening and diagnostic services.

      • Donors & Volunteers
          • Donate Home
          • Raise Money
          • Honor Loved Ones
          • Create Your Legacy
          • Endowments
          • Caring Fund
          • Matching Gifts
          • Foundation and Corporation Relations
          • Volunteer Home
          • Why Volunteer
          • On-Site Volunteers
          • Volunteer Endowment
          • Patient Experience
          • Teen Volunteer Leadership Program
          • Children's Cancer Hospital Councils
          • Other Ways to Help Home
          • Give Blood
          • Shop UT MD Anderson
          • Children's Art Project
          • Donate Goods or Services
          • Attend Events
          • Cord Blood Bank
          • Corporate Alliances Home
          • Current Alliances
        • Join the Campaign to End Cancer 

          Help us celebrate and fuel the groundbreaking innovations and transformative advancements that define UT MD Anderson.

      • For Physicians
          • Refer a Patient Home
          • Health Care Provider Resource Center
          • Referring Provider Team
          • Insurance Information
          • International Referrals
          • myMDAnderson for Physicians
          • Second Opinion Pathology
          • Clinical Trials Home
          • Clinical Tools & Resources Home
          • Clinical Calculators
          • Clinical Practice Algorithms
        • myMDAnderson for Physicians 

          Our personalized portal helps you refer your patients and communicate with their UT MD Anderson care team.

      • Research
          • Departments, Labs and Institutes Home
          • Departments and Divisions
          • Labs
          • Research Centers and Programs
          • Institutes
          • Specialized Programs of Research Excellence (SPORE) Grants
          • Research Areas Home
          • Basic Science
          • Translational Research
          • Clinical Research
          • Prevention & Personalized Risk Assessment
          • Research Resources Home
          • Excellence in Science
          • Core Facilities and Services
          • Conferences & Seminars
          • Why Research at UT MD Anderson
          • STRIDE
          • NCI-Designated Cancer Center
          • Data Resources
        • Clinical Trials 

          As part of our mission to eliminate cancer, UT MD Anderson researchers conduct hundreds of clinical trials to test new treatments for both common and rare cancers.

      • Education & Training
          • Degree-Granting Schools Home
          • School of Health Professions
          • MD Anderson UTHealth Houston Graduate School
          • Research Training Home
          • Early Career Pathway Programs
          • Predoctoral Training
          • Postdoctoral Training
          • Mentored Faculty Programs
          • Career Development
          • Clinical Training Home
          • Graduate Medical Education
          • Clinical Education for Non-Physicians
          • Nursing Education & Training
          • Continuing Education & Review Courses
          • Simulation Center
          • Continuing Education & Professional Development Home
          • Continuing Professional Education/Conferences
          • Administrative Internships & Fellowships
          • Cancer Survivorship Professional Education
          • Leadership Institute
          • Patient Home Visits
          • Education Resources Home
          • Alumni Relations
          • Education Design Services
          • Awards & Recognitions
          • Academic Mentoring Council
          • Why UT MD Anderson & Houston
          • Outreach Programs Home
          • Project ECHO
          • Observer Programs
          • Comparative Effectiveness Training (CERTaIN)
          • Faculty Speakers Bureau
        • Apply to SHP

          Choose from 12 allied health programs at School of Health Professions.

          Research Trainees

          View open postdoctoral and other research trainee positions.

          GME Fellowships

          Learn about our graduate medical education residency and fellowship opportunities.

      Tongxin Xie Image

      Tongxin Xie, MD,PHD

      Department of Head and Neck Surgery, Division of Surgery

      Present Title & Affiliation

      Primary Appointment

      Assistant Professor, Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas

      Instructor, Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas

      Professor, Department of Pathology, Hebei Medical University, Shijiazhuang

      Associate Professor, Department of Pathology, Hebei Medical University, Shijiazhuang

      Assistant Professor, Department of Pathology, Hebei Medical University, Shijiazhuang

      Instructor, Hebei Medical University, Hebei Medical University, Shijiazhuang

      Education & Training

      Degree-Granting Education

      2000Oita Medical University, Oita, JP, Philosophy, PhD
      1987Hebei Medical University, Shijiazhuang, CN, Medicine/ Pathology, MS
      1983Hebei Medical University, Shijiazhuang, CN, Medicine, MD

      Postgraduate Training

      2005-2006Postdoctoral Fellow, The University of Texas MD Anderson Cancer Center, Houston, Texas
      2002-2005Postdoctoral Fellow, The University of Texas MD Anderson Cancer Center, Houston, Texas
      2000-2002Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center, Houston, Texas
      1983-1984Resident, Baoding Hospital, Baoding
      1981-1983Intern, Hebei Medical University Affiliated Hospitals, Shijiazhuang, Texas

      Honors & Awards

      2002Awesome Job Award in Education, The University of Texas MD Anderson Cancer Center
      1998 - PresentThe First Prize of Scientific and Technological Advance, The Scientific and Technological Committee of Hebei Province, China
      1997 - PresentThe Third Prize of Scientific and Technological Advance, The Scientific and Technological Committee of Hebei Province, China
      1996 - PresentThe Third Prize of Scientific and Technological Advance, The Scientific and Technological Committee of Hebei Province
      1995 - PresentThe Third Prize of Scientific and Technological Advance, The Scientific and Technological Committee of Hebei Province
      1995 - PresentAward of Ten Excellent College Teachers, Hebei Province
      1995 - PresentExcellent Paper Award, Japanese Society of Clinical Pathology
      1995 - 1996One of Ten Significant Achievements of Science and Technology in China in 1995, The Scientific and Technological Committee of China
      1993 - PresentThe Third Prize of Scientific and Technological Advance, The Scientific and Technological Committee of Hebei Province
      1992 - PresentThe Third Prize of Scientific and Technological Advance, The Scientific and Technological Committee of Hebei Province
      1992 - PresentThe Fourth Prize of Scientific and Technological Advance, The Scientific and Technological Committee of Hebei Province
      1990 - PresentThe Third Prize of Scientific and Technological Advance, Ministry of Public Health

      Grant & Contract Support

      Date: 2025 - 2027
      Title:Defining the impact of cancer-induced nerve injury on the tumor immune microenvironment
      Funding Source:IRG
      Role:PI
      Date: 2022 - 2024
      Title:Molecular alterations in reprogrammed tumor associated nerves and their role in perineural invasion
      Funding Source:IRG
      Role:PI
      Title:Decoding L1CAM-EGFR Signaling in Schwann Cells: Unraveling Neuroimmune Interactions in Head and Neck Cancer
      Funding Source:NIH/NCI, R01
      Role:PI

      Selected Publications

      Peer-Reviewed Articles

      1. Liu, N, Shi, X, Chen, S, Chen, H, Santi, MD, Phuong, DM, Fialho, MP, Xie, T, Gleber-Netto, FO, Latorre, R, Bunnett, NW, Viet, CT, Amit, M, Pan, H, Ye, Y. EGFR activation sensitizes trigeminal NMDA receptors to promote pain and morphine analgesic tolerance in oral cancer. Science Signaling 19(922):eadt3026, 2026. e-Pub 2026. PMID: 41592151.
      2. Zhang, M, Yuan, M, Asam, K, Gong, Z, Xie, T, Gleber-Netto, FO, Santi, MD, Kobayashi, Y, Shimizu, E, Aouizerat, B, Amit, M, Boada, MD, Ye, Y. Perineural Invasion Exhibits Traits of Neurodegeneration. Journal of Dental Research 104(12):1352-1360, 2025. e-Pub 2025. PMID: 40492439.
      3. Baruch EN, Gleber-Netto FO, Nagarajan P, Rao X, Akhter S, Eichwald T, Xie T, Balood M, Adewale A, Naara S, Sathishkumar HN, Islam S, McCarthy W, Mattson BJ, Ferrarotto R, Wong MK, Davies MA, Jindal S, Basu S, Roversi K, Nikpoor AR, Ahmadi M, Ahmadi A, Harwood C, Leigh I, Gong D, Tallon de Lara P, Tao DL, Davidson TM, Ajami NJ, Futreal A, Rai K, Kochat V, Castillo M, Gunaratne P, Goepfert RP, Hernandez SD, Khushalani NI, Wang J, Watowich SS, Calin GA, Migden MR, Yuan M, Liu N, Ye Y, Hwang WL, Vermeer PD, D'Silva NJ, Bunimovich YL, Yaniv D, Burks JK, Gomez J, Dougherty PM, Tsai KY, Allison JP, Sharma P, Wargo JA, Myers JN, Talbot S, Gross ND, Amit M. Cancer-induced nerve injury promotes resistance to anti-PD-1 therapy. Nature, 2025. e-Pub 2025. PMID: 40836096.
      4. Islam, S, Gleber-Netto, FO, Mulcahy, CF, Glaun, MD, Srivastava, S, Hunt, PJ, Williams, MD, Barbon, CE, Spiotto, MT, Zhao, W, Adebayo, A, Akhter, S, Xie, T, Debnath, KC, Sathishkumar, HN, Myers, B, Lothumalla, S, Yaman, I, Burks, JK, Gomez, JA, Rao, X, Wang, J, Woodman, K, Mansour, J, Arenkiel, BR, Osman, KL, Haxton, C, Lever, TE, Hutcheson, KA, Amit, M. Neural landscape is associated with functional outcomes in irradiated patients with oropharyngeal squamous cell carcinoma. Science translational medicine 16(758):eabq5585, 2024. e-Pub 2024. PMID: 39083586.
      5. Pifer, PM, Yang, L, Kumar, M, Xie, T, Frederick, MJ, Hefner, A, Beadle, BM, Molkentine, D, Molkentine, JM, Dhawan, A, Abdelhakiem, M, Osman, AA, Leibowitz, BJ, Myers, JN, Pickering, CR, Sandulache, VC, Heymach, JV, Skinner, H. FAK Drives Resistance to Therapy in HPV-Negative Head and Neck Cancer in a p53-Dependent Manner. Clinical Cancer Research 30(1):187-197, 2024. e-Pub 2024. PMID: 37819945.
      6. Shi, Y, Ren, X, Cao, S, Chen, X, Yuan, B, Brasil da Costa, FH, Rodriguez-Rosario, AE, Corona, A, Michikawa, C, Veeramachaneni, R, Osman, AA, Xie, T, Wang, W, Sikora, AG, Myers, JN, Rangel, R. TP53 gain-of-function mutation modulates the immunosuppressive microenvironment in non-HPV-associated oral squamous cell carcinoma. Journal for immunotherapy of cancer 11(8), 2023. e-Pub 2023. PMID: 37604640.
      7. Ye, Y, Xie, T, Amit, M. Targeting the Nerve–Cancer Circuit. Cancer Research 83(15):2445-2447, 2023. e-Pub 2023. PMID: 37470842.
      8. Baruch, EN, Nagarajan, P, Gleber-Netto, FO, Rao, X, Xie, T, Akhter, S, Adewale, A, Shajedul, I, Mattson, BJ, Ferrarotto, R, Wong, MK, Davies, MA, Jindal, S, Basu, S, Harwood, C, Leigh, I, Ajami, NJ, Futreal, A, Castillo, M, Gunaratne, PH, Goepfert, RP, Khushalani, N, Wang, J, Watowich, SS, Calin, GA, Migden, MR, Vermeer, PD, D'Silva, NJ, Yaniv, D, Burks, JK, Gomez, JA, Dougherty, PM, Tsai, KY, Allison, JP, Sharma, P, Wargo, J, Myers, JN, Gross, N, Amit, M. Inflammation induced by tumor-associated nerves promotes resistance to anti-PD-1 therapy in cancer patients and is targetable by interleukin-6 blockade. Research square, 2023. e-Pub 2023. PMID: 37503252.
      9. Chen, Y‐, Zhao, W, Na'ara, S, Netto, FG, Xie, T, Ali, S, Thompson, Z, Buell, J, Stafford, H, Nagarajan, P, Davies, MA, Wong, MK, Migden, MR, Sharma, P, Myers, JN, Gross, N, Amit, M. Beta-Blocker Use Is Associated With Worse Relapse-Free Survival in Patients With Head and Neck Cancer. JCO Precision Oncology 7:e2200490, 2023. e-Pub 2023. PMID: 37285560.
      10. Amit, M, Xie, T, Netto, FG, Hunt, PJ, Mehta, GU, Bell, D, Silverman, DA, Yaman, I, Ye, Y, Burks, JK, Fuller, GN, Gidley, PW, Nader, M, Raza, SM, DeMonte, F. Distinct immune signature predicts progression of vestibular schwannoma and unveils a possible viral etiology. Journal of Experimental and Clinical Cancer Research 41(1), 2022. e-Pub 2022. PMID: 36195959.
      11. Shi, Y, Xie, T, Wang, B, Wang, R, Cai, Y, Yuan, B, Netto, FG, Tian, X, Rodriguez-Rosario, AE, Osman, AA, Wang, J, Pickering, CR, Ren, X, Sikora, AG, Myers, JN, Rangel, R. Mutant p53 drives an immune cold tumor immune microenvironment in oral squamous cell carcinoma. Communications Biology 5(1), 2022. e-Pub 2022. PMID: 35902768.
      12. Santi, MD, Zhang, M, Salvo, E, Asam, K, Viet, CT, Xie, T, Amit, M, Aouizerat, B, Ye, Y. Schwann Cells Induce Phenotypic Changes in Oral Cancer Cells. Advanced Biology 6(9), 2022. e-Pub 2022. PMID: 35925609.

      Review Articles

      1. Santi, MD, Zhang, M, Liu, N, Viet, CT, Xie, T, Jensen, DD, Amit, M, Pan, H, Ye, Y. Repurposing EGFR Inhibitors for Oral Cancer Pain and Opioid Tolerance. Pharmaceuticals 16(11), 2023. e-Pub 2023. PMID: 38004424.
      2. Yaman, I, Çobanoğlu, DA, Xie, T, Ye, Y, Amit, M. Advances in understanding cancer-associated neurogenesis and its implications on the neuroimmune axis in cancer. Pharmacology and Therapeutics 239, 2022. e-Pub 2022. PMID: 35490859.
      3. Batalla-Covello, J, Ali, S, Xie, T, Amit, M. β-Adrenergic signaling in skin cancer. FASEB BioAdvances 4(4):225-234, 2022. e-Pub 2022. PMID: 35415461.

      Editorials

      1. Shi, Y, Tang, X, Xie, T, Zhang, Y, Ren, X. Editorial. Frontiers in Neurology 14, 2023. PMID: 37602237.

      Abstracts

      1. Pickering C, Kumar M, Bridges K, Xie T, Molkentine D, Sheth A, Yang L, Frederick M, Heffernan T, Seth S, Myers J, Skinner HD. Targeting histone acetyltransferase (HAT) function for synthetic cytotoxicity in CREBBP/EP300 mutant tumors. Proceedings of the American Association for Cancer Research Annual Meeting 2019, 2019. e-Pub 2019.
      2. Colbert LE, Kumar M, Yang L, Molkentine D, Bridges, Kathleen, Myers JN, Xie T, Frederick MJ, Pickering C, Skinner, Heath. In Vivo shRNA Screening Reveals Differential Radiosensitization Within HPV+ and HPV- Head and Neck Squamous Cell Carcinomas. International Journal of Radiation Oncology*Biology*Physics, 2018. e-Pub 2018.
      3. Huang C, Moorthy S, Li Q, Saade R, Wang J, Rao X, Tanaka N, Zhang J, Tang L, Pickering CR, Zweidler-McKay PA, Osman AA, Xie T, Shinbrot E, Xi L, Wheeler D, El-Naggar AK, Wang J, Myers JN, Frederick MJ. NOTCH1 activation in head and neck squamous cell carcinoma leads to growth inhibition, changes in gene expression associated with early differentiation, and acquisition of stem cell-like properties. Proceedings of the American Association for Cancer Research Annual Meeting 2018, 2018. e-Pub 2018.
      4. Xie T. In Vivo Screening Identifies ESR1 as a Clinically Relevant Target for Radiosensitization In HNSCC. International Journal of Radiation Oncology • Biology • Physics, 2018. e-Pub 2018.
      5. Xie T. In-vivo shRNA screening identifies synthetic cytotoxicity in CREBBP/EP300 mutant head and neck cancer. AACR Meeting-2018, 2018. e-Pub 2018.
      6. Pickering CR, Xie T, Kumar M, Parimi RL, Yang LP, Wang J, Seth S, Bristow CA, Carugo A, Robinson FS, Draetta GF, Skinner H, Frederick MJ, Myers JN. In vivo shRNA library screening to identify novel targets for head and neck squamous cell carcinoma [abstract]. Proceedings of the American Association for Cancer Research Annual Meeting 2017, 2017. e-Pub 2017.
      7. Xie T, Parimi RL, Kumar MF, Yang LP, Wang J, Seth S, Alessandro C, Bristow CA, Robinson FS, Peoples MD, Skinner H, Myers JN, Pickering CR, Frederick MJ. An in vivo high throughput shRNA screening platform for identifying ways to target genomic alterations [abstract]. Proceedings of the AACR-AHNS Head and Neck Cancer Conference: Optimizing Survival and Quality of Life through Basic, Clinical, and Translational Research, 2017. e-Pub 2017.
      8. Xie T, Zhou G, Zhao M, Lozano G, Brennan R, Myers JN. Serine substituion of proline at codon 151 of TP53 leads to anoikis resistance, soft agar growth, and enhanced in vivo tumorigenicity of head and neck cancer cells and a putative conformational change within a hydrophobic subdomain of the p53 protein. 4th International Workshop on Mutant p53: “In vivo effects of mutant p53: experimental data, animal, models, clinical consequences”, 2009. e-Pub 2009.
      9. Xie TX, Zhou G, Zhao M, Jasser SA, Myers JN. A mutant p53 promotes anoikis resistance by down-regulating Bmf in oral squamous carcinoma cells. 7th International Conference on Head and Neck Cancer 2008, 2008. e-Pub 2008.
      10. Zhou G, Zhao M, Xie TX, Jasser SA, Myers JN. Gain of function of p53 mutations disrupt the ATM-mediated DNA damage response in HNSCC cell lines. 7th International Conference on Head and Neck Cancer 2008, 2008. e-Pub 2008.
      11. Xie TX, Zhou G, Jasser SA, Zhao M, Wu X, Myers JN. Detachment-induced over expression of XIAP promotes resistance to anoikis of oral squamous carcinoma cells by down-regulating Htra2-Omi through ubiquitination. American Association for Cancer Research Annual Meeting 2008, 2008. e-Pub 2008.
      12. Zhou G, Xie TX, Zhao M, Jasser S, Younes M, Sano D, Lin J, Kupferman M, Santillan A, Patel V, Gutkind JS, El-Naggar A, Emberely E, Watson P, Matsuzawa S, Reed J, Myers JN. Reciprocal negative regulation between S100A7/psoriasin and beta-catenin signaling plays an important role in tumor progression of squamous cell carcinoma of oral cavity. American Association for Cancer Research Annual Meeting 2008, 2008. e-Pub 2008.
      13. Zhou G, Mandal M, Jasser SA, Zhao M, Dakak-Yazici Y, Xie TX, Younes MN, Kupferman ME, Patel V, Gutkind JS, EI-Naggar AK, Emberley ED, Watson PH, Bucana CD, Myers JN. Psoriasin/S100A7 modulates β-catenin signaling and inhibits tumor growth and progression of oral cavity squamous cell carcinoma. American Association for Cancer Research Annual Meeting 2007, 2007. e-Pub 2007.
      14. Aoki K, Misiumi J, Kimura T, Zhao W, Xie TX. Evaluation of Cutoff Levels for screening of gastric cancer using serum pepsinogen. Jan. J. Hyg 58(1):1, 2003. e-Pub 2003.
      15. Zhao W, Zhang X, Aoki K, Zhang Z, Xie TX, Kudo M, Bo YH, Kono A, Mi JM, Akshi H, Esaki F, Kurakake S, Misumi J. Differences in drinking water composition between three areas with different gastric cancer motalityrates in Zanhuang county, China. International Symposium on Biology of Cancer Prevention and Treatment 30, 1999. e-Pub 1999.
      16. Aoki K, Misumi J, Zhao W, Kono A, Esaki, F, Xie TX, Zhang XH, Zhang ZG. Prevalence of helicobacter pylori infection in three areas with different gastric mortality rate in Zanhuang County in China. International Symposium on Biology of Cancer Prevention and Treatment 30, 1999. e-Pub 1999.
      17. Wang FR, Zhang XH, Xie TX, Ma HJ, Zhang ZD. Mycotoxins and lung cancer. The 6th World Conference on Lung Cancer, 1991. e-Pub 1991.
      18. Xie TX, Wang FR, Zhang ZD. Photolysis of sterigmatocystin by sunlight. Chinese Journal of Preventive Medicine 22:22, 1991. e-Pub 1991.
      19. Zhang X, Xie TX, Wang JL, Yan X, Lu LM, Wang ZY, Wang FR. Carcinogenesis studies of the extract of aspergillus versicolor culture on the human fetal lung tissues in vitro. The 6th World Conference on International Lung Cancer, 1991. e-Pub 1991.

      Book Chapters

      1. Xie T. Tissue culture and sample preparation of cell suspension. In: Techniques of sample preparation for flow cytometry. In: Hua Xia Press: Beijing, China, 1991, 1991.
      Read More
      Less

      Patient Reviews


      CV information above last modified July 22, 2026

      Request an Appointment

      Whether you are ready to make an appointment now or have questions for our expert team, we are standing by to help.
      Learn more

      Related Links

      • Care Centers and Clinics

      • Departments and Divisions

      • Labs

      Clinical Trials

      Our patients have access to clinical trials offering promising new treatments that cannot be found anywhere else.
      Learn more

      Help #EndCancer

      Give Now

      Your gift will help make a tremendous difference.
      Donate

      Donate Blood

      Our patients depend on blood and platelet donations.

      Make an appointment

      Shop UT MD Anderson

      Show your support for our mission through branded merchandise.

      View products
      Subscribe to our Cancerwise newsletter
      UT MD Anderson logoUT MD Anderson logo
      • Explore
      • Patients & Family
      • Prevention & Screening
      • Donors & Volunteers
      • For Physicians
      • Research
      • Education & Training
      • Clinical Trials
      • Languages
      • About
      • About UT MD Anderson
      • Careers
      • Blog
      • Newsroom
      • Editorial Standards
      • For Employees
      • Merchandise
      • Title IX Reporting (Sexual Misconduct)
      • Price Transparency
      • Finding Your Way
      • Our Doctors
      • Locations
      • Directions
      • Sitemap
      • DIGITAL ACCESSIBILITY
      • Accessibility Policy MD Anderson works with Level Access to ensure our website is accessible and functional for all users. Free assistive technology is provided for people with physical disabilities. To learn more or to download the assistive technology tool, visit https://www.levelaccess.com/MDAnderson
      • GET IN TOUCH
      • Call
        1-877-632-6789
      • Ask a question
      • Stay Connected
      • Cancerwise Podcast
      • More
      • Website Privacy Policy
      • Legal Statement & Policies
      • Reports to the State
      • Emergency Alert Information
      • State of Texas Links
      • Our Cancer Network
      • Vendors & Suppliers
      UT MD Anderson logo
      The mission of The University of Texas MD Anderson Cancer Center is to eliminate cancer in Texas, the nation, and the world through outstanding programs that integrate patient care, research and prevention, and through education for undergraduate and graduate students, trainees, professionals, employees and the public.

      © 2026 The University of Texas MD Anderson Cancer Center. All rights reserved.

      Top